Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: mTOR signaling pathway (mmu04150)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
2610019A
05Rik
KLA  ATP  ATP+KLA
 NM_028126 RIKEN cDNA 2610019A05 gene (2610019A05Rik), mRNA [NM_028126] KLA .93 .91 .93 .91 .92 1.01 1.01
ATP 1.02 1.04 1.10 1.14 .84 .69 1.00
KLA/ATP .93 .92 .97 .94 .79 .73 .84
4921505C
17Rik
KLA  ATP  ATP+KLA
 NM_030168 RIKEN cDNA 4921505C17 gene (4921505C17Rik), mRNA [NM_030168] KLA 1.61 1.58 1.65 1.38 1.39 1.22 1.26
ATP .99 .98 1.04 1.11 1.55 1.22 1.03
KLA/ATP 1.68 1.70 1.46 1.49 1.51 1.30 1.28
4932417H
02Rik
KLA  ATP  ATP+KLA
 AK029341 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832440O09 product:Hypothetical ARM repeat structure containing protein, full insert sequence. [AK029341] KLA .90 .86 .81 .84 .93 .84 .93
ATP 1.00 1.06 1.02 .88 .93 .76 1.06
KLA/ATP .90 .86 .88 .79 .83 .80 .98
4932417H
02Rik
KLA  ATP  ATP+KLA
 NM_028898 RIKEN cDNA 4932417H02 gene (4932417H02Rik), mRNA [NM_028898] KLA .76 .72 .83 .63 .61 .68 .75
ATP .99 .95 .79 .76 .66 .62 1.47
KLA/ATP .78 .71 .56 .50 .39 .48 .89
AK045366
KLA  ATP  ATP+KLA
 AK045366 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230107A03 product:unclassifiable, full insert sequence [AK045366] KLA .88 .80 .79 .86 .89 .97 1.07
ATP 1.21 1.67 2.40 3.50 2.58 1.29 1.12
KLA/ATP .97 .98 1.30 1.76 1.26 1.15 1.06
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt1s1
KLA  ATP  ATP+KLA
 NM_026270 AKT1 substrate 1 (proline-rich) (Akt1s1), mRNA [NM_026270] KLA .66 .69 .64 .71 .95 1.13 1.31
ATP 1.10 1.12 .89 1.14 1.38 1.66 1.14
KLA/ATP .73 .65 .56 .85 1.33 1.68 1.11
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Braf
KLA  ATP  ATP+KLA
 NM_139294 Braf transforming gene (Braf), mRNA [NM_139294] KLA 1.52 1.57 1.55 1.33 1.83 1.52 1.60
ATP 1.08 1.17 1.02 1.37 .95 1.15 .95
KLA/ATP 1.64 1.69 1.39 1.51 1.04 1.31 1.26
Cab39
KLA  ATP  ATP+KLA
 NM_133781 calcium binding protein 39 (Cab39), mRNA [NM_133781] KLA .77 .75 .65 .73 .77 1.15 1.04
ATP .88 .81 .69 .52 .75 1.11 1.23
KLA/ATP .69 .64 .57 .45 .70 .93 1.46
Cab39l
KLA  ATP  ATP+KLA
 NM_026908 calcium binding protein 39-like (Cab39l), mRNA [NM_026908] KLA 2.28 2.34 2.61 2.45 2.53 2.16 1.16
ATP .99 .95 1.04 .95 .84 1.04 1.15
KLA/ATP 2.00 2.14 2.11 2.36 1.91 1.84 1.58
Ddit4
KLA  ATP  ATP+KLA
 NM_029083 DNA-damage-inducible transcript 4 (Ddit4), mRNA [NM_029083] KLA .59 .59 .64 .70 .58 .59 .52
ATP .53 .36 2.78 7.00 6.68 12.80 1.34
KLA/ATP .53 .68 5.47 12.86 9.74 8.93 2.95
Eif4b
KLA  ATP  ATP+KLA
 NM_145625 eukaryotic translation initiation factor 4B (Eif4b), mRNA [NM_145625] KLA .93 .95 .95 .80 .75 .73 .97
ATP 1.08 1.19 1.04 1.43 1.34 1.48 1.04
KLA/ATP 1.13 1.07 .93 1.10 .98 1.19 1.55
Eif4e
KLA  ATP  ATP+KLA
 NM_007917 eukaryotic translation initiation factor 4E (Eif4e), mRNA [NM_007917] KLA 1.22 1.06 .94 .97 .83 .85 1.18
ATP 1.00 1.01 1.27 1.27 2.61 2.08 .97
KLA/ATP .95 1.04 1.37 1.16 1.50 1.28 .73
Eif4e2
KLA  ATP  ATP+KLA
 NM_001039169 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 2, mRNA [NM_001039169] KLA 1.53 1.51 1.54 1.52 1.55 1.49 1.55
ATP 1.02 1.08 1.12 1.45 1.61 1.51 1.15
KLA/ATP 1.56 1.60 1.59 1.90 1.90 1.75 1.68
Eif4e2
KLA  ATP  ATP+KLA
 NM_023314 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 3, mRNA [NM_023314] KLA 1.42 1.40 1.43 1.35 1.58 1.65 1.42
ATP 1.06 1.06 1.04 .98 1.41 2.07 2.04
KLA/ATP 1.46 1.48 1.40 1.45 1.64 2.12 2.30
Eif4ebp1
KLA  ATP  ATP+KLA
 NM_007918 eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1), mRNA [NM_007918] KLA .66 .64 .59 .67 .81 .97 .97
ATP .97 .94 1.10 1.05 1.99 1.60 .91
KLA/ATP .62 .61 .68 .68 1.50 1.24 .95
Frap1
KLA  ATP  ATP+KLA
 NM_020009 FK506 binding protein 12-rapamycin associated protein 1 (Frap1), mRNA [NM_020009] KLA 1.37 1.32 1.46 1.57 1.83 1.29 1.28
ATP 1.12 1.07 .95 .91 .80 .77 1.03
KLA/ATP 1.45 1.51 1.50 1.11 .89 .87 1.01
Gbl
KLA  ATP  ATP+KLA
 NM_019988 G protein beta subunit-like (Gbl), mRNA [NM_019988] KLA .43 .37 .36 .45 .56 .77 1.10
ATP .94 .79 .71 .49 .56 1.42 .90
KLA/ATP .40 .37 .35 .29 .49 1.30 .86
Hif1a
KLA  ATP  ATP+KLA
 NM_010431 hypoxia inducible factor 1, alpha subunit (Hif1a), mRNA [NM_010431] KLA 2.52 2.50 2.52 1.78 1.87 1.39 1.96
ATP 1.16 1.37 1.11 1.44 2.11 4.46 1.97
KLA/ATP 2.76 2.92 1.75 2.60 2.39 4.75 5.37
Igf1
KLA  ATP  ATP+KLA
 AK050118 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730016P09 product:unclassifiable, full insert sequence. [AK050118] KLA .13 .14 .15 .16 .22 .34 .48
ATP 1.78 2.05 1.37 .72 .34 .41 .58
KLA/ATP .24 .45 .50 .24 .20 .26 .68
Igf1
KLA  ATP  ATP+KLA
 NM_010512 insulin-like growth factor 1 (Igf1), transcript variant 1, mRNA [NM_010512] KLA .84 .78 .76 .67 .54 .48 .59
ATP .97 .98 1.13 1.13 1.03 .88 .89
KLA/ATP .82 .81 .93 .86 .83 .65 .89
Igf1
KLA  ATP  ATP+KLA
 NM_184052 insulin-like growth factor 1 (Igf1), transcript variant 2, mRNA [NM_184052] KLA .77 .82 .76 .65 .60 .52 .69
ATP 1.01 1.07 .98 1.06 1.03 .78 .94
KLA/ATP .89 .86 .77 .80 .75 .65 .89
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ins1
KLA  ATP  ATP+KLA
 NM_008386 insulin I (Ins1), mRNA [NM_008386] KLA 1.00 .99 .99 1.03 1.01 .98 1.06
ATP .97 1.03 1.00 1.03 .99 1.07 1.05
KLA/ATP 1.03 .93 .98 1.04 1.07 1.03 1.01
Ins2
KLA  ATP  ATP+KLA
 NM_008387 insulin II (Ins2), mRNA [NM_008387] KLA .99 1.00 1.00 1.01 1.00 1.02 1.00
ATP 1.01 .99 1.00 1.00 .98 .99 1.01
KLA/ATP .99 1.01 1.00 .98 .99 .99 .98
Irs1
KLA  ATP  ATP+KLA
 NM_010570 insulin receptor substrate 1 (Irs1), mRNA [NM_010570] KLA .97 .96 .99 1.01 .93 .94 .94
ATP 1.00 .99 1.02 .96 .96 .94 .91
KLA/ATP .96 .96 .98 .96 .97 .98 .92
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mm.19092
2
KLA  ATP  ATP+KLA
 51921310 Unknown KLA .69 .65 .55 .55 .48 .47 .49
ATP .96 .95 .79 .64 .45 .49 .44
KLA/ATP .66 .65 .62 .54 .45 .45 .42
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.29002
2
KLA  ATP  ATP+KLA
 167234371 Unknown KLA .53 .50 .44 .38 .36 .39 .57
ATP 1.01 1.07 1.01 1.02 .84 .42 .40
KLA/ATP .53 .51 .38 .41 .47 .40 .21
Pdpk1
KLA  ATP  ATP+KLA
 NM_011062 3-phosphoinositide dependent protein kinase-1 (Pdpk1), transcript variant 1, mRNA [NM_011062] KLA .90 .90 .84 1.00 1.32 1.19 1.15
ATP 1.05 1.09 1.04 1.14 1.31 .97 1.17
KLA/ATP .90 .89 .91 1.02 1.27 .96 1.42
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Prkaa1
KLA  ATP  ATP+KLA
 NM_001013367 protein kinase, AMP-activated, alpha 1 catalytic subunit (Prkaa1), mRNA [NM_001013367] KLA 1.10 1.03 1.17 1.25 1.24 1.61 2.29
ATP 1.04 1.07 1.10 1.08 1.04 2.01 2.13
KLA/ATP 1.07 1.04 1.04 1.17 .95 1.90 3.90
Prkaa2
KLA  ATP  ATP+KLA
 NM_178143 protein kinase, AMP-activated, alpha 2 catalytic subunit (Prkaa2), mRNA [NM_178143] KLA .93 .94 .94 .90 .92 .92 .99
ATP 1.00 1.14 .93 1.01 1.00 1.11 .98
KLA/ATP 1.00 .97 .99 1.01 .98 1.02 .98
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Pten
KLA  ATP  ATP+KLA
 NM_008960 phosphatase and tensin homolog (Pten), mRNA [NM_008960] KLA .79 .73 .61 .59 .56 .70 1.00
ATP 1.04 1.11 1.07 1.12 1.03 1.38 .83
KLA/ATP .75 .69 .60 .74 .93 1.09 1.24
Rheb
KLA  ATP  ATP+KLA
 NM_053075 RAS-homolog enriched in brain (Rheb), mRNA [NM_053075] KLA 1.03 1.00 .99 .99 .95 1.03 1.09
ATP .99 .89 .95 .81 1.07 1.19 .90
KLA/ATP 1.01 .87 .97 .82 1.06 1.22 .88
Rps6
KLA  ATP  ATP+KLA
 AK013825 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900086I01 product:ribosomal protein S6, full insert sequence. [AK013825] KLA 1.04 1.06 1.03 .99 .94 .96 1.26
ATP 1.01 1.00 1.04 .99 .99 .94 1.12
KLA/ATP 1.02 1.08 .95 1.04 .94 .97 .90
Rps6
KLA  ATP  ATP+KLA
 NM_009096 ribosomal protein S6 (Rps6), mRNA [NM_009096] KLA 1.01 1.01 .94 .87 .89 .66 .72
ATP 1.11 1.07 1.10 1.12 1.12 1.03 .47
KLA/ATP .96 1.04 1.22 1.10 .86 .84 .40
Rps6ka1
KLA  ATP  ATP+KLA
 NM_009097 ribosomal protein S6 kinase polypeptide 1 (Rps6ka1), mRNA [NM_009097] KLA .64 .65 .58 .62 .78 .94 .98
ATP .87 .85 .78 .74 .58 .68 .82
KLA/ATP .59 .52 .55 .50 .50 .63 .77
Rps6ka2
KLA  ATP  ATP+KLA
 NM_011299 ribosomal protein S6 kinase, polypeptide 2 (Rps6ka2), mRNA [NM_011299] KLA 1.67 1.69 1.70 1.29 1.50 1.32 1.40
ATP 1.02 1.02 .99 1.28 3.97 3.73 1.32
KLA/ATP 1.90 1.63 1.74 1.99 2.45 2.84 1.59
Rps6ka3
KLA  ATP  ATP+KLA
 NM_148945 ribosomal protein S6 kinase polypeptide 3 (Rps6ka3), mRNA [NM_148945] KLA 2.00 2.37 2.65 2.59 2.40 1.41 .96
ATP 1.09 1.09 1.17 1.29 1.11 1.63 1.83
KLA/ATP 2.44 2.44 2.63 3.13 1.99 1.66 2.09
Rps6ka6
KLA  ATP  ATP+KLA
 NM_025949 ribosomal protein S6 kinase polypeptide 6 (Rps6ka6), mRNA [NM_025949] KLA .98 1.03 1.06 .99 1.01 1.06 1.01
ATP .96 1.00 .97 .92 1.06 1.01 1.00
KLA/ATP .95 1.01 1.01 .97 1.00 .95 1.00
Rps6kb1
KLA  ATP  ATP+KLA
 NM_001114334 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 1, mRNA [NM_001114334] KLA .99 1.00 .90 .89 .99 .99 .92
ATP 1.01 .96 1.00 .79 1.36 1.19 .72
KLA/ATP 1.08 .99 .93 .92 1.18 .90 .56
Rps6kb1
KLA  ATP  ATP+KLA
 NM_028259 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 2, mRNA [NM_028259] KLA 1.01 .93 1.07 1.04 .99 .99 .98
ATP 1.09 1.05 1.00 1.01 1.08 1.03 1.03
KLA/ATP 1.07 1.04 .94 .98 1.03 1.05 1.05
Rps6kb2
KLA  ATP  ATP+KLA
 AK090093 kidney CCL-142 RAG cDNA, RIKEN full-length enriched library, clone:G430107K15 product:ribosomal protein S6 kinase, 70kD, polypeptide 2, full insert sequence [AK090093] KLA .97 1.01 .98 .97 .98 1.04 1.07
ATP 1.00 1.08 1.06 1.09 1.11 1.06 1.03
KLA/ATP 1.05 .96 .86 1.03 1.40 1.07 .99
Rps6kb2
KLA  ATP  ATP+KLA
 NM_021485 ribosomal protein S6 kinase, polypeptide 2 (Rps6kb2), mRNA [NM_021485] KLA 1.36 1.40 1.45 1.40 1.63 1.57 1.46
ATP 1.08 1.19 .97 1.15 .90 .99 1.34
KLA/ATP 1.44 1.55 1.09 1.39 1.00 1.12 1.77
Rraga
KLA  ATP  ATP+KLA
 NM_178376 Ras-related GTP binding A (Rraga), mRNA [NM_178376] KLA .76 .80 .77 .75 .70 .72 .88
ATP .84 1.13 1.37 1.64 1.04 .93 .96
KLA/ATP .72 .84 .96 1.10 1.01 .97 .90
Rragb
KLA  ATP  ATP+KLA
 NM_001004154 Ras-related GTP binding B (Rragb), mRNA [NM_001004154] KLA .72 .75 .63 .66 .59 .55 .59
ATP 1.01 .94 .73 .70 .59 .59 .58
KLA/ATP .74 .69 .65 .73 .62 .54 .59
Rragc
KLA  ATP  ATP+KLA
 NM_017475 Ras-related GTP binding C (Rragc), mRNA [NM_017475] KLA .88 .93 1.12 .99 1.05 .88 .88
ATP 1.03 1.16 .96 1.09 1.33 1.15 1.44
KLA/ATP .92 .99 .80 1.20 1.60 1.57 1.28
Rragd
KLA  ATP  ATP+KLA
 NM_027491 Ras-related GTP binding D (Rragd), mRNA [NM_027491] KLA .58 .57 .54 .50 .42 .42 .88
ATP .97 1.03 1.00 1.12 2.86 2.16 2.82
KLA/ATP .56 .58 .61 .66 1.53 1.72 2.31
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tsc1
KLA  ATP  ATP+KLA
 AK083363 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920023H23 product:tuberous sclerosis 1, full insert sequence. [AK083363] KLA .69 .66 .60 .71 .85 .78 .77
ATP 1.13 1.26 1.70 2.23 1.77 .87 .90
KLA/ATP .76 .77 .90 1.19 1.74 .80 .72
Tsc1
KLA  ATP  ATP+KLA
 NM_022887 tuberous sclerosis 1 (Tsc1), mRNA [NM_022887] KLA .93 .94 1.00 1.04 1.01 .95 1.10
ATP 1.12 1.10 1.12 1.27 1.66 1.45 1.80
KLA/ATP .95 1.00 1.06 1.03 1.26 1.30 1.74
Tsc2
KLA  ATP  ATP+KLA
 NM_011647 tuberous sclerosis 2 (Tsc2), transcript variant 1, mRNA [NM_011647] KLA .91 .88 .87 .83 .83 .88 .99
ATP .91 .91 1.04 .88 .76 .68 .91
KLA/ATP .88 .89 .88 .76 .65 .67 .85
Ulk1
KLA  ATP  ATP+KLA
 NM_009469 Unc-51 like kinase 1 (C. elegans) (Ulk1), mRNA [NM_009469] KLA .53 .52 .53 .56 .64 .75 .75
ATP .94 .90 1.05 1.13 1.49 1.82 .61
KLA/ATP .53 .49 .56 .62 1.32 2.23 1.24
Ulk2
KLA  ATP  ATP+KLA
 AK087234 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030037L18 product:unclassifiable, full insert sequence. [AK087234] KLA .76 .67 .70 .77 .91 .80 .73
ATP 1.13 1.07 .75 .65 .88 .75 .67
KLA/ATP .75 .66 .90 .74 .88 .74 .74
Ulk2
KLA  ATP  ATP+KLA
 NM_013881 Unc-51 like kinase 2 (C. elegans) (Ulk2), mRNA [NM_013881] KLA .62 .59 .58 .56 .51 .48 .62
ATP 1.06 .99 .79 .63 .40 .35 .48
KLA/ATP .61 .61 .49 .51 .37 .28 .38
Ulk3
KLA  ATP  ATP+KLA
 AK004783 adult male lung cDNA, RIKEN full-length enriched library, clone:1200015E14 product:hypothetical Serine [AK004783] KLA .64 .62 .68 .90 1.07 1.24 1.11
ATP .98 .92 1.13 .81 .52 .96 1.03
KLA/ATP .66 .67 .80 .68 .82 .92 .96
Vegfa
KLA  ATP  ATP+KLA
 NM_001025250 vascular endothelial growth factor A (Vegfa), transcript variant 1, mRNA [NM_001025250] KLA .49 .48 .46 .46 .39 .64 1.18
ATP 1.05 1.37 3.82 10.55 12.51 24.20 7.85
KLA/ATP .48 .59 1.45 7.42 19.75 27.42 22.35
Vegfa
KLA  ATP  ATP+KLA
 NM_001025257 vascular endothelial growth factor A (Vegfa), transcript variant 3, mRNA [NM_001025257] KLA .72 .71 .66 .70 .65 .80 1.22
ATP 1.01 1.21 3.24 11.12 11.09 18.59 5.43
KLA/ATP .68 .71 1.47 5.94 15.06 20.32 17.31